Molecular mechanisms of interplay between RORγ/RORγT receptors and cyclin-dependent kinase inhibitor (AT7519). Analysis of tissue-specific interaction and activation of Th17 lymphocytes.

2019/35/N/NZ7/01618

Keywords

Descriptors

  • NZ7_015: Toksykologia
  • NZ7_012: Prewencja chorób człowieka
  • NZ2_006: Immunogenetyka

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Biologii Medycznej PAN

Voivodeship: łódzkie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Kaja Urszula Karaś

Number of co-investigators in the project: 2

Call

PRELUDIUM 18 – announced on 2019-09-16

Amount awarded
139 920 PLN
Project start date
2020-07-02
Project end date
2024-07-01
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519

    Authors:
    Kaja Karaś, Iwona Karwaciak, Katarzyna Chałaśkiewicz, Anna Sałkowska, Joanna Pastwińska, Rafał A. Bachorz, Marcin Ratajewski
    Academic press:
    Biomedicine & Pharmacotherapy (year: 2023, volume: 164, pages: 115002), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biopha.2023.115002 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski